Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization

Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth

DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has signed a definitive agreement to divest assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing in building market-leading, technology-rich healthcare companies.

By divesting these businesses, Fortrea aims to advance the growth strategy and solutions of Endpoint and Fortrea Patient Access, positioning them for increased investment to accelerate the technology roadmap and further enhance operations to support best-in-class customer solutions and delivery. The remaining business of Fortrea will strengthen its focus on clinical development phases 1 through 4. Closing is targeted for the second quarter of 2024, subject to customary closing conditions and regulatory approvals, as well as the parties entering into certain services and operating agreements.

“Today marks a significant milestone in Fortrea’s ongoing journey, as we sharpen our focus on organically growing as a pure-play CRO, with added financial flexibility,” said Fortrea Chairman and CEO Tom Pike. “After undertaking a strategic review of our business, divesting Endpoint and Fortrea Patient Access aligns with the interests of our customers. Arsenal has extensive experience in building businesses that create systematic improvement in health outcomes, and I am confident that Endpoint and Fortrea Patient Access will be able to strengthen their market positions, nurture top-tier talent and invest in new capabilities and resources while delivering solutions that improve patients’ lives.”

“I am excited for this next chapter for Endpoint and Fortrea Patient Access,” said Sam Osman, president of Enabling Services at Fortrea, who will serve as the CEO of these businesses with Arsenal. “These businesses will be distinctively positioned to effectively manage the patient journey across clinical trials and into commercialization by driving patient access and adherence for approved therapies. Combining Arsenal’s deep investment acumen and leading industry operational expertise, I am confident the Endpoint and Fortrea Patient Access businesses are well positioned for growth and delivery of enhanced capabilities for patients and pharma sponsors. I look forward to our continued positive impact on healthcare.”

“Endpoint and Fortrea Patient Access have a proud, decades-long track record of market leadership in supporting clinical research and commercialization of innovative therapies. Arsenal takes pride in building organizations that meaningfully improve healthcare. We are excited to partner with management and employees to accelerate the growth of these two businesses,” said Gene Gorbach, an Investment Partner of Arsenal.

Dimitris Agrafiotis, Ph.D., Director of Digital, Analytics & AI at Arsenal said, “Endpoint and Fortrea Patient Access provide essential solutions that enable patients’ participation in clinical trials and access to therapies. I am delighted to support the talented team at Endpoint and Fortrea Patient Access. Together, we will further enhance the sophistication of technology capabilities that underpin these companies’ commitment to delivering the highest quality services to the pharmaceutical industry.”

Endpoint Clinical
Endpoint operates in the high growth eClinical market as a leading provider of Randomization and Trial Supply Management (RTSM) solutions to biopharmaceutical and CRO customers with expertise in serving complex and late-stage clinical trials. For more than 15 years, Endpoint has had a successful track record of effectively supporting more than 1,750 clinical trials involving 875,000 patients across 90 countries and has cultivated a blue-chip customer base and nurtured long-standing strategic relationships.

Fortrea Patient Access
Fortrea Patient Access is a scaled leader in the HUB services and patient access market, serving the biopharmaceutical industry with comprehensive patient support, product access, affordability and adherence solutions for more than 30 years. Further advanced by its recently expanded non-commercial specialty pharmacy, FortreaRx™, to support enhanced distribution of cold-chain and ambient free goods products, Fortrea Patient Access is committed to driving patient outcomes and improving healthcare accessibility through its extensive experience while currently supporting more than 2.5 million patients and over 100 unique brands across more than 25 disease indications.

Arsenal Capital Partners
Arsenal Capital Partners is a leading private equity investment firm that specializes in building market-leading industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds totaling over $10 billion, completed more than 290 platform and add-on acquisitions, and achieved more than 35 realizations. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add.  For more information, visit www.arsenalcapital.com.

Advisors
Barclays is serving as exclusive financial advisor to Fortrea, and Smith Anderson is serving as its legal counsel. Sidley Austin LLP served as Arsenal’s legal counsel.

Earnings Call and Replay
Fortrea will discuss the divestiture announcement on its fourth quarter 2023 earnings conference call, which will be held today at 9:00 am ET. The conference can be accessed through the Fortrea Investor Relations website or the following earnings webcast link. To avoid potential delays, please join at least 10 minutes prior to the start of the call. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea website. A supplemental slide presentation will also be available on the Fortrea Investor Relations website prior to the start of the call.

About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, consulting services, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of about 18,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the anticipated benefits of the transaction, including future financial and operating performance, and the anticipated timing for completing the transaction. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “guidance,” “expect,” “assume,” “anticipate,” “intend,” “plan,” “forecast,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results could differ materially from these forward looking statements due to a number of factors, including, but not limited to: satisfaction of the conditions precedent to consummation of the proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses transaction, including the ability to secure regulatory approvals, and the Company’s ability to complete the transaction in a timely manner or at all; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; the parties’ ability to meet expectations regarding the accounting and tax treatments of the proposed transaction; and other factors described from time to time in documents that the Company files with the SEC. For a further discussion of the risks relating to the Company’s business, see the “Risk Factors” Section of the Company’s Registration Statement on Form 10, as filed with the Securities and Exchange Commission (the “SEC”), as such factors may be amended or updated from time to time in the Company’s subsequent periodic and other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included or incorporated by reference in this report and in the Company’s filings with the SEC. All forward-looking statements are made only as of the date of this report and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments.

Fortrea Contacts:
Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com

Arsenal Contact:
Jackie Schofield at  pro-Arsenal@prosek.com

GlobeNewswire Distribution ID 9061141

Recursion Announces Plans to Open New Office in London

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood

LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced plans to open a new office in London’s vibrant King’s Cross neighborhood. Set to formally open in June 2024, the site will provide Recursion and Valence Labs, the company’s artificial intelligence research engine, access to world-class talent across Europe’s rapidly growing TechBio sector and embed Recursion in a thriving innovation ecosystem of leading technology and life science companies.

“As Recursion continues to lead and define the TechBio industry, it’s critical we hire the best possible talent, much of which is located in Europe,” said Chris Gibson, Ph.D., Co-founder and CEO at Recursion. “London stood out as an ideal location given its brilliant and interdisciplinary talent across the fields of technology, biology and chemistry. It’s also the epicenter for the rapidly growing TechBio sector in Europe, where leading technology and life science companies like Google and Merck both sit within walking distance of our new Recursion site. I look forward to expanding our operations in Europe and hiring many new Recursionauts who will help us advance our mission of decoding biology to radically improve lives.”

To support Recursion’s leadership in TechBio and entry into London, the company is excited to announce the addition of Michael Bronstein, DeepMind Professor of Artificial Intelligence at Oxford University, as a Scientific Advisor. Professor Bronstein is a world leader in geometric deep learning, graph neural networks, and protein design. Professor Bronstein joins AI luminary Professor Yoshua Bengio in supporting Recursion and Valence Labs in the development of state-of-the-art AI models to support the industrialization of drug discovery.

“Recursion is leading the field in advancing cutting-edge AI research for real-world applications with the potential to radically improve lives, and I’m honoured to join them in their mission,” said Prof Michael Bronstein. “I have collaborated with Valence prior to their acquisition by Recursion, and I look forward to continuing to work with the team to advance this important work, especially as Recursion continues to grow in London.”

Recursion’s 6,700 square foot London office will be located at 3 Pancras Square, King’s Cross London. The building is part of a 67-acre redevelopment project in the heart of King’s Cross, with over 4.5 million square feet of office space. Located within a 3-minute walk from King’s Cross Station and St. Pancras International, the site offers excellent transit access. The building includes an onsite cafe, bicycle storage, showers, prayer room and mothers room. In line with Recursion’s commitment to sustainability, the building meets the requirements for an “Excellent” rating by BREEAM building standards and is linked to a site-wide district heating and cooling network that results in net-zero carbon emissions.

“The UK Government’s plan for attracting more inward investment into the UK is working. Recursion’s investment is yet another vote of confidence in the UK, our top talent and our amazing tech and life sciences industries,” said Investment Minister Lord Johnson. “I’m delighted Recursion has chosen London, and we’ll continue to do everything we can to ensure the UK remains the top choice for investments like this.”

Today, Recursion has over 500 employees with a near-equal mix of life scientists and technologists across sites in Salt Lake City, Toronto, Montréal, and the San Francisco Bay Area. Recursion’s new London office will serve as an extension of both Recursion and Valence Labs’ teams. To launch recruiting efforts for the new site, Recursion has opened multiple new roles across technology and biology functions with immediate plans to hire the first 20 people to be based out of the new London office. Recursion and Valence Labs will also host a TechBio Mixer tomorrow, March 12, at the location of its new site to celebrate the office and network with the TechBio community.

For more information on open positions and to apply, visit recursion.com/careers and valencelabs.com/careers.

About Recursion
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological, chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, chemistry and patient-centric data to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

Forward-Looking Statements
This document contains information that includes or is based upon “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding the opening of the London office and timing of such opening; the recruitment efforts and number of roles at the London office; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as “plan,” “will,” “expect,” “anticipate,” “intend,” “believe,” “potential,” “could,” “continue,” and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023. All forward-looking statements are based on management’s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.

GlobeNewswire Distribution ID 9060948

Recursion Announces Plans to Open New Office in London

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood

LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced plans to open a new office in London’s vibrant King’s Cross neighborhood. Set to formally open in June 2024, the site will provide Recursion and Valence Labs, the company’s artificial intelligence research engine, access to world-class talent across Europe’s rapidly growing TechBio sector and embed Recursion in a thriving innovation ecosystem of leading technology and life science companies.

“As Recursion continues to lead and define the TechBio industry, it’s critical we hire the best possible talent, much of which is located in Europe,” said Chris Gibson, Ph.D., Co-founder and CEO at Recursion. “London stood out as an ideal location given its brilliant and interdisciplinary talent across the fields of technology, biology and chemistry. It’s also the epicenter for the rapidly growing TechBio sector in Europe, where leading technology and life science companies like Google and Merck both sit within walking distance of our new Recursion site. I look forward to expanding our operations in Europe and hiring many new Recursionauts who will help us advance our mission of decoding biology to radically improve lives.”

To support Recursion’s leadership in TechBio and entry into London, the company is excited to announce the addition of Michael Bronstein, DeepMind Professor of Artificial Intelligence at Oxford University, as a Scientific Advisor. Professor Bronstein is a world leader in geometric deep learning, graph neural networks, and protein design. Professor Bronstein joins AI luminary Professor Yoshua Bengio in supporting Recursion and Valence Labs in the development of state-of-the-art AI models to support the industrialization of drug discovery.

“Recursion is leading the field in advancing cutting-edge AI research for real-world applications with the potential to radically improve lives, and I’m honoured to join them in their mission,” said Prof Michael Bronstein. “I have collaborated with Valence prior to their acquisition by Recursion, and I look forward to continuing to work with the team to advance this important work, especially as Recursion continues to grow in London.”

Recursion’s 6,700 square foot London office will be located at 3 Pancras Square, King’s Cross London. The building is part of a 67-acre redevelopment project in the heart of King’s Cross, with over 4.5 million square feet of office space. Located within a 3-minute walk from King’s Cross Station and St. Pancras International, the site offers excellent transit access. The building includes an onsite cafe, bicycle storage, showers, prayer room and mothers room. In line with Recursion’s commitment to sustainability, the building meets the requirements for an “Excellent” rating by BREEAM building standards and is linked to a site-wide district heating and cooling network that results in net-zero carbon emissions.

“The UK Government’s plan for attracting more inward investment into the UK is working. Recursion’s investment is yet another vote of confidence in the UK, our top talent and our amazing tech and life sciences industries,” said Investment Minister Lord Johnson. “I’m delighted Recursion has chosen London, and we’ll continue to do everything we can to ensure the UK remains the top choice for investments like this.”

Today, Recursion has over 500 employees with a near-equal mix of life scientists and technologists across sites in Salt Lake City, Toronto, Montréal, and the San Francisco Bay Area. Recursion’s new London office will serve as an extension of both Recursion and Valence Labs’ teams. To launch recruiting efforts for the new site, Recursion has opened multiple new roles across technology and biology functions with immediate plans to hire the first 20 people to be based out of the new London office. Recursion and Valence Labs will also host a TechBio Mixer tomorrow, March 12, at the location of its new site to celebrate the office and network with the TechBio community.

For more information on open positions and to apply, visit recursion.com/careers and valencelabs.com/careers.

About Recursion
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological, chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, chemistry and patient-centric data to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

Forward-Looking Statements
This document contains information that includes or is based upon “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding the opening of the London office and timing of such opening; the recruitment efforts and number of roles at the London office; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as “plan,” “will,” “expect,” “anticipate,” “intend,” “believe,” “potential,” “could,” “continue,” and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023. All forward-looking statements are based on management’s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.

GlobeNewswire Distribution ID 9060948

Namibian Correctional Service maintain top spot in Southern Division league


OPUWO: The Namibian Correctional Service Football Club maintained its lead in the Southern Stream First Division after defeating rivals Blue Boys Football Club (FC) and Eleven Arrows FC in two consecutive games over the weekend.

The Correctional Service squad has emerged as a formidable challenger in the league since it started, having signed some of the country’s best talents during its recruiting process last year. On Saturday, NCS defeated Eleven Arrows 2-1 before upsetting Blue Boys 2-0, their closest competitor for the league crown. The weekend results have extended NCS’s winning streak to eight games, a tie, and one defeat, with 25 points at the top of the log standing.

In other Saturday games, Davos defeated Oranjemund 2-1, and former Namibia Premier League stronghold Black Africa, which is currently in turmoil due to infighting among its top leaders, suffered another defeat after a humiliating 6-2 loss to Dates Eleven. Deutscher Turn und Sportverein (DTS) beat Try Again 3-1, while Blue Boys outscore
d Latinos 4-1.

In Sunday’s results, Ramblers played to a one-all draw against Dates Eleven. At the same time, Davos defeated Try Again in a 5-1 goal thriller, while DTS was humiliated by Oranjemund in their home stadium, losing five goals to nil. Latinos fell at home to Eleven Arrows, and Black Africa lost 3-1 to Mariental Sport Club.

Some clubs in the league have played 10 or 11 games, while Ramblers and DTS have played nine, with Black Africa playing the fewest (four). NCS currently lead the league with 25 points, followed by Blue Boys with 22 points and Eleven Arrows in third with 18 points.

Dates Eleven, Mariental Sports Club, and Davos all have 17 points, placing fourth, fifth and sixth, respectively. Try Again are seventh in the log standing with 12 points, followed by Latinos in eighth place with 11 points. Ramblers and Oranjemund FC are in ninth and 10th place with 10 points, respectively, while DTS are in 11th place with seven points. Black Africa are comfortably in the relegation zone after faili
ng to secure a single point in all of its matches.

Source: The Namibia Press Agency

Eleven Warriors FC reduce top gap in NWFD Footbal League


OPUWO: Eleven Warriors Football Club (FC) defeated league favourites KK Palace 4-1 at Grootfontein’s Omulunga Stadium on Sunday, reducing the gap at the top of the Northwest First Division (NWFD) Football League.

However, before overcoming KK Palace on Sunday, Eleven Warriors FC experienced the same fate on Saturday, losing to the revived African Motto by a single goal. KK Palace however won away from home against Touch and Go 1-0 in Otavi.

Oshikuku Young Stars suffered a 1-0 defeat at home to Golden Bees, while Ongwediva City and Outjo Football Academy (OFA) drew 0-0.

Young Chiefs beat Onambula United 2-0, while Golden Bigs defeated Khuse Lions 1-0 on Saturday.

On Sunday, relegation-threatened OFA defeated Oshikuku Young Stars 1-0, while Golden Bees and Ongwediva United drew 0-0. African Motto, who were at the bottom of the log standings last weekend, have now moved out of the relegation zone after a 5-0 thrashing of Touch and Go in Otavi, while Golden Bigs and Onambula United drew 2-2, and Young Chiefs
were defeated 2-0 by Khuse Lions in Oshakati.

The race is still on in the NWFD’s 12-team race, with any of the top four teams still having a chance to win the championship at the end of the season. Only four points separate the first and fourth-placed teams.

Despite losing to Eleven Warriors on Sunday, KK Palace remains the league leader with 26 points after 13 games played. Eleven Warriors, who appeared to be a real challenger, are two points behind KK Palace in second place. Golden Bees and Onambula United are still in the fight, with 22 points apiece in third and fourth place.

Young Chiefs and Golden Bigs are in fifth and sixth place, respectively, with 19 points, and they, too, are not far from the championship dream. Ongwediva City is in seventh place with 18 points, followed by Khuse Lions in eighth and Oshikuku in ninth, both with 16 points.

The revived African Motto, who appear to have rediscovered their feet, has risen two places up to the tenth place with 14 points, leaving OFA and Touch and Go
in the relegation zone with 13 and eight points respectively.

Source: The Namibia Press Agency

Ntunguru condemn Omuthiya United FC to seventh game without a win


OPUWO: Ntunguru Football Club cruised to a comfortable 4-0 victory over Omuthiya United on Sunday, deepening Omuthiya’s relegation worries and registering their second win in the Northeast First Division league.

The victory propelled them into third place on the log standings from ninth place after seven matches.

The weekend results leave Omuthiya United FC in the relegation zone, still without a win after seven games, with just three draws and a 14-goal difference at the bottom of the table.

Ntunguru FC, on the other hand, recorded their first win this weekend, defeating Tsumed-based Chiefs Santos 2-1 on Saturday before thumping Omuthiya United 4-0 on Sunday.

Other teams that recorded victories on Saturday include Eastern Chiefs, who incapacitated Further Fighters’ defence in a 4-1 victory, with Black Hawks going down at home to Oshikango Chiefs by one goal. Omuthiya United, who are struggling in top-flight football, suffered a 1-0 home setback to Kangweru Black Tops on Saturday. United Stars upset Cuca
Tops 2-1, albeit suffering KK United earned their first victory, defeating Rundu Chiefs 1-0.

Eastern Chiefs lost 2-1 to Oshikango Chiefs on Sunday, Black Hawks overcame Further Fighters by one goal, and Chiefs Santos, who lost on Saturday, won by three goals to one at home against Kangweru Black Tops. United Stars and Rundu Chiefs drew 1-1 in a Rundu derby, while KK United fell 2-1 to Cuca Tops.

With all clubs having played seven games, Oshikango Chiefs lead the league with 17 points from five wins and two draws, followed by United Stars with 13.

Ntunguru, Eastern Chiefs, Black Hawks, and Kangweru Black Tops all have 11 points, ranking third, fourth, fifth, and sixth, respectively. Cuca Tops are seventh on the log standing with 10 points, followed by Chiefs Santos in eighth with eight points. Rundu Chiefs are in ninth place with six points, followed by Further Fighters and KK United, who each have five points. Omuthiya United remained in the relegation zone, in 12th place after seven games without a point.

Source: The Namibia Press Agency

Hamukwaya calls for increased inclusivity for para-athletes


SWAKOPMUND: Secretary General of the Namibia Paralympic Committee, Michael Hamukwaya, has called for inclusivity for para-athletes in sports competitions, including the recently concluded Rössing Uranium Marathon.

In a recent interview with Nampa, Hamukwaya expressed his wish for an elite para-athlete category to be introduced to the marathon, enabling disabled athletes to showcase their skills and abilities.

‘The Rössing Marathon is one of the largest in the country, and para-athletes across the nation have only had the opportunity to participate for enjoyment, not necessarily for any prize money. So, this year, we decided to take an extra step and entered two of our elite wheelchair para-athletes to compete in the 42.2-kilometre race for people, including the organisers, to realise that paralympics are not just about participation, but can also be competitive,’ Hamukwaya noted.

According to the secretary general, although there were a few setbacks during the race such as flat tires, it was a learning exp
erience, and the para-athletes successfully completed the race.

‘Essentially, we entered to demonstrate our seriousness. These para-athletes have the capability to go the distance, with the appropriate equipment, if they were given the platform. We hope we have convinced the organisers of these events,’ Hamukwaya added.

Roodley Gawaseb, one of the para-athletes who participated in the Rössing Marathon, echoed Hamukwaya’s sentiments, stating that including them in these local competitions where they can compete for prizes would assist them in raising funds to cover travel expenses for international competitions.

‘We truly want organisers of these events to consider including us because as it stands, we are really struggling to finance these trips. As much as we want to enhance our skills and improve our times, attending as many competitions as possible is challenging because we have to seek funding for everything ourselves. If we do not have an opportunity to win any prizes, then we cannot do that,’ Gawaseb
said, adding that he intends to prepare and hopefully qualify for the Sanlam Marathon in South Africa, scheduled for October this year, and the Commonwealth Games next year.

Source: The Namibia Press Agency

Treat Kavango as a special case: Mbangu


RUNDU: Rundu Rural Constituency councillor Paulus Mbangu has said Central Government has not properly addressed poverty in the two Kavango regions over the past 34 years and called on it to treat the regions as a special case.

Mbangu made the statement recently in a meeting the regional leadership of the Kavango East Region had with Minister of Mines and Energy, Tom Alweendo, on rural electrification.

He said scientific data and evidence indicating that the two Kavango regions are the poorest have been collected during Income Expenditure Surveys and by the United Nations Development Programme over the years, and at no point did Cabinet or Government use this data to address poverty in the two regions.

‘It’s not an exaggeration when we say that Central Government has been too ignorant of the plight of our people. The planning of resources and allocation, be it in rural electrification or other sectors, has never been informed by these data, thus carrying out surveys in the country is pointless,’ Mbangu comp
lained.

The councillor further claimed that there is ‘serious energy poverty’ in the Kavango regions as well.

‘Houses are in darkness. If our government was a caring government, it would mobilise resources to bring these regions up to par with other affluent regions,’ he said.

Mbangu went on to state that the current ongoing electrification of schools project is not addressing energy poverty in the Kavango East Region.

Electricity, he added, is a catalyst for development, and communities are still in darkness while schools have been electrified.

He thus called on the ministry to start electrifying villages and to treat the Kavango regions as a special case as informed by the scientific data.

In response to Mbangu’s statements, Alweendo said the ministry has not neglected electrifying households, but prioritised public institutions first in order to clear that backlog.

Chairperson of the Kavango East Regional Council, Damian Maghambayi said rural electrification was moving very slowly in the region, par
ticularly electrification to rural household communities.

Household electrification, he said, is a central pillar of national development efforts, and a primary tool to address and alleviate poverty.

Source: The Namibia Press Agency

MIT hosts Assistance and Protection against Chemical Weapons training course


WINDHOEK: A six-day advanced course on Assistance and Protection against Chemical Weapons for Anglophones States Parties commenced in the capital on Monday.

Hosted by the Ministry of Industrialisation and Trade, the course is a continuation of the Anglophone Training Cycle which started in 2023 and is held in collaboration with the Organisation for the Prohibition of Chemical Weapons (OPCW).

Addressing the participants, Industrialisation and Trade Minister, Lucia Iipumbu said the training aims to strengthen the capacities of the first responders of the Anglophone States Parties in preparedness capabilities and response to chemical incidents.

‘To this end, I am extremely happy that the programme for this workshop is of a practical nature and participants will not solely be limited to theoretical presentation,’ she said.

Iipumbu noted that although Namibia has made progress towards the completion of the Chemical Weapons Act, a lot needs to be done to ensure that the country domesticates the Convention by pr
omulgating the law.

Speaking at the same event, Programme Officer at the OPCW, Babatunde Olowookere said the training will allow participants to refresh the knowledge acquired in the preceding basic level training and expand that knowledge to include more comprehensive chemical emergency functions.

Training courses of this nature are organised along with the indications received from the OPCW Policy Making Organs to make effective use of the available regional capacities and resources.

Source: The Namibia Press Agency

Two people die in car accident


ONETHINDI: The Namibian Police Force (NamPol) in the Oshikoto Region opened a case of drunk driving against a 36-year-old Toyota Hilux driver after he reportedly hit a Toyota Corolla, resulting in the deaths of two people.

The deceased are the 43-year-old driver of the Corolla and an unknown female, who was a passenger in the same vehicle.

According to the region’s crime investigations coordinator, Deputy Commissioner Titus Ekandjo on Monday, the accident occurred pon Sunday around 21h00 between the Onethindi and Onandjokwe State Hospital road in Oshikoto’s Oniipa Constituency.

The driver of the Toyota Hilux pickup was not injured and was arrested for alleged drunk driving, and is currently admitted at Onandjokwe State Hospital for observation under police guard.

‘It is alleged that the driver of the white Toyota Corolla which was travelling from Onethindi towards Onandjokwe State Hospital’s direction was trying to make a U-turn while the white Toyota Hilux, which was travelling from Onandjokwe towards On
ethindi, was close,’ reported Ekandjo.

He added that in the process the pickup hit the sedan on the left side, resulting in the death of the Toyota Corolla driver and the passenger on the spot. The incident also caused injuries to other passengers from both vehicles.

The deceased’s remains were transported to the Onandjokwe State Hospital mortuary for post-mortem purposes and investigations continue.

Source: The Namibia Press Agency

Woman arrested for attempted murder at Otjiwarongo


OTJIWARONGO: A 40-year-old woman at Otjiwarongo was arrested on Sunday after she allegedly stabbed her boyfriend in the Ombili informal settlement after an argument.

Namibian Police Force (NamPol) Otjozondjupa Regional Crime Investigations Coordinator, Deputy Commissioner Edna Nawa, in an interview with Nampa on Monday said the 38-year-old male victim survived the alleged stabbing and was admitted to the Otjiwarongo State Hospital in a critical condition.

‘The victim was transported to the hospital with the knife still stuck in his right shoulder,’ said Nawa.

The police officer added that the knife was however successfully removed by a medical doctor at the Otjiwarongo State Hospital.

The victim’s condition was described as critical but stable on Monday, Nawa said.

The suspect faces a charge of attempted murder and is expected to appear in the Otjiwarongo Magistrate’s Court on Tuesday.

Police investigations continue.

Source: The Namibia Press Agency

Migratory red locusts in Zambezi


KATIMA MULILO: Farmers and members of the public are informed and warned of the presence of African migratory red locusts in some parts of the Zambezi Region’s river field areas and Ohangwena Region, respectively.

In a media release by the Ministry of Agriculture, Water and Land Reform dated 07 March 2024, the African migratory red locusts have been detected and reported, as of 29 February 2024, in the Zambezi Region notably at Lake Liambezi and Old Masokotwani, destroying maize crops. The locusts are reported to be in the hopper and flying stages, respectively. To date 10 hectares have been destroyed by the locusts.

Furthermore, farmers in the surrounding areas such as Kapani, Kanono, Linyanti, Nakabolelwa, Masikili, Ngoma, Isuswa, Ioma, Mutikitila, Ibbu, Mahundu, Ngala, Chinchimae, Singobeka, Maunga, Sangwali and Oshikunde village in the Oshikunde Constituency are urged to be on the lookout and report any notable locust outbreak to the ministry or constituency office.

Locusts pose a serious threat to cro
ps in general and river field crops and livestock grazing areas.

Meanwhile, the ministry is said to have deployed extension officials to intensify surveillance to monitor and assess the situation and are advised to commence with ground spraying in the affected areas.

Source: The Namibia Press Agency

Power outage at Hochfeld Substation


WINDHOEK: NamPower on Monday announced that a power outage was recorded at the Hochfeld Substation on Sunday, which affected areas such as Midgard Lodge, Ovitoto Village and the surrounding areas, leaving them without power.

In a media statement issued by Area Manager, Collin Klein, the power utility indicated that residents in these areas have been without power since 19h19 on Sunday.

‘The prevailing situation is due to a broken lightening arrester pole at the Hochfeld Substation that caused damages to the 66kV Red Phase breaker leg,’ noted the statement.

Klein further assured that Nampower’s technical personnel are currently attending to the problem, while cautioning the public to treat all power lines and electrical points as live during power outages, until they are informed that the power has been restored.

Source: The Namibia Press Agency

Rape-accused pastor apprehended at Omusati


OSHAKATI: The Namibian Police Force (NamPol) in the Omusati Region has arrested a pastor who was wanted for allegedly raping a 15-year-old girl at Okando village in the Oshikuku Constituency between June 2020 and September 2022.

NamPol Omusati Crime Investigations Coordinator, Deputy Commissioner Moses Simaho, said the suspect was arrested on Monday and is expected to appear in the Outapi Magistrate’s Court on Tuesday.

According to Simaho, the matter was only reported to the police last week Thursday.

‘It is alleged that the suspect had sexual intercourse with a minor several times on different occasions during the above-mentioned time frame,’ he said.

He added that the matter was reported by the 18-year-old woman who lives with the victim.

Police investigation into the matter continues.

Source: The Namibia Press Agency

ECN to reach out to young voters


WINDHOEK: The Electoral Commission of Namibia (ECN) has launched its democracy awareness campaign with a particular focus on increasing youth participation in the electoral process.

The commission has acknowledged the need to encourage the youth to register as voters in the upcoming general voter registration from 03 June to August 2024.

ECN last week announced that all eligible Namibian voters will have to register to vote ahead of the presidential and national assembly elections in November 2024.

The democracy awareness campaign, which is part of the voter and civic education campaign for the registration of voters, is themed the Step Up Campaign under the slogan ‘Step up for your right, register to vote.’

ECN Commissioner Gerson Tjihenuna said that to encourage the youth, information, education materials, and campaigns will have the slogan ‘Your future lies with youth, step up and register to vote.’

He said to ensure active youth participation, the ECN will make use of youth ambassadors to influence t
he participation of young people in the electoral process.

‘The ECN is cognisant of the fact that the youth constitute the highest number of eligible voters in Namibia, however, their turnout during electoral processes has been low. To ensure youth participation during the upcoming electoral processes, the ECN has to come up with programmes and strategies aimed at promoting their participation,’ he said during the launch of ECN electoral calendar and awareness campaign last week.

Meanwhile, the electoral commission has picked Ms Teen Namibia, Oriana Ribeiro, as the lead youth ambassador for its voter and civic education.

Ribeiro told Nampa that for young people to secure their future, they must participate in the democratic process.

‘It is important for young people like me to get involved in the electoral process by registering and voting. What we need to realise is that Namibia is our future. We need to start taking initiative and contributing in meagre ways to our society. The first step we need to tak
e is to cultivate the kind of future we want. And we can do that by voting and being part of the electoral process,’ said the 19-year-old first-time voter.

Source: The Namibia Press Agency